ENTX Entera Bio Ltd.
$3.06▲ +6.99%
Healthcare
Other
After hours
$3.12▲ +1.96%
Oct 27, 4:20 PM ET
Volume 203.5K
Avg Volume (10D) 720.7K
Key Metrics & Fundamentals
Market Cap
$532.20M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.91 - 4.20
% vs 50 MA
5.82%
% vs 200 MA
62.51%
RSI-14
59.2
MACD Histogram
+0.0400
Beta (1Y vs SPY)
0.85
Free Cash Flow
-$3.47M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$4.55M
COGS
$0
Operating Exp
$4.56M
Operating Income
-$4.56M
EBIT
-$4.56M
Pretax Income
-$7.31M
Net Income
-$7.31M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
GlobeNewswire · Oct 27, 2026 8:00 AM ET
Eloxx Pharmaceuticals Appoints Biopharmaceutical Industry Veteran Geno Germano to its Board of Directors
PR Newswire · Oct 19, 2026 4:05 PM ET
Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting
GlobeNewswire · Oct 13, 2026 7:00 AM ET
Top Premarket Decliners
MT Newswires · Oct 9, 2026 7:40 AM ET
Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting
GlobeNewswire · Oct 8, 2026 8:00 AM ET
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
GlobeNewswire · Oct 6, 2026 8:00 AM ET
Guggenheim Initiates Entera Bio at Buy With $11 Price Target
MT Newswires · Sep 25, 2026 6:34 AM ET
Correction: Entera to Participate in Upcoming Fall Investor Conferences
GlobeNewswire · Aug 27, 2026 9:44 AM ET
Entera to Participate in Upcoming Fall Investor Conferences
GlobeNewswire · Aug 27, 2026 8:00 AM ET
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
GlobeNewswire · Aug 18, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Mar 2025
See ENTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.